Literature DB >> 11158131

Expression of Babesia equi merozoite antigen 1 in insect cells by recombinant baculovirus and evaluation of its diagnostic potential in an enzyme-linked immunosorbent assay.

X Xuan1, A Larsen, H Ikadai, T Tanaka, I Igarashi, H Nagasawa, K Fujisaki, Y Toyoda, N Suzuki, T Mikami.   

Abstract

The gene encoding the entire Babesia equi merozoite antigen 1 (EMA-1) was inserted into a baculovirus transfer vector, and a recombinant virus expressing EMA-1 was isolated. The expressed EMA-1 was transported to the surface of infected insect cells, as judged by an indirect fluorescent-antibody test (IFAT). The expressed EMA-1 was also secreted into the supernatant of a cell culture infected with recombinant baculovirus. Both intracellular and extracellular EMA-1 reacted with a specific antibody in Western blots. The expressed EMA-1 had an apparent molecular mass of 34 kDa that was identical to that of native EMA-1. The secreted EMA-1 was used as an antigen in an enzyme-linked immunosorbent assay (ELISA). The ELISA differentiated B. equi-infected horse sera from Babesia caballi-infected horse sera or normal horse sera. The ELISA was more sensitive than the complement fixation test and IFAT. These results demonstrated that the recombinant EMA-1 expressed in insect cells might be a useful diagnostic reagent for detection of antibodies to B. equi.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11158131      PMCID: PMC87800          DOI: 10.1128/JCM.39.2.705-709.2001

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  18 in total

1.  Immunisation with recombinant AMA-1 protects mice against infection with Plasmodium chabaudi.

Authors:  R F Anders; P E Crewther; S Edwards; M Margetts; M L Matthew; B Pollock; D Pye
Journal:  Vaccine       Date:  1998 Jan-Feb       Impact factor: 3.641

2.  Prevalence of equine piroplasmosis in Central Mongolia.

Authors:  A Avarzed; D T De Waal; I Igarashi; A Saito; T Oyamada; Y Toyoda; N Suzuki
Journal:  Onderstepoort J Vet Res       Date:  1997-06       Impact factor: 1.792

3.  Characterization of canine herpesvirus glycoprotein C expressed by a recombinant baculovirus in insect cells.

Authors:  X Xuan; K Maeda; T Mikami; H Otsuka
Journal:  Virus Res       Date:  1996-12       Impact factor: 3.303

4.  Baculovirus expression of the major surface antigen of Toxoplasma gondii and the immune response of mice injected with the recombinant P30.

Authors:  X G Chen; M C Fung; X Ma; H J Peng; S M Shen; G Z Liu
Journal:  Southeast Asian J Trop Med Public Health       Date:  1999-03       Impact factor: 0.267

5.  Baculovirus merozoite surface protein 1 C-terminal recombinant antigens are highly protective in a natural primate model for human Plasmodium vivax malaria.

Authors:  K L Perera; S M Handunnetti; I Holm; S Longacre; K Mendis
Journal:  Infect Immun       Date:  1998-04       Impact factor: 3.441

6.  Immunogenicity and in vitro protective efficacy of a recombinant multistage Plasmodium falciparum candidate vaccine.

Authors:  Y P Shi; S E Hasnain; J B Sacci; B P Holloway; H Fujioka; N Kumar; R Wohlhueter; S L Hoffman; W E Collins; A A Lal
Journal:  Proc Natl Acad Sci U S A       Date:  1999-02-16       Impact factor: 11.205

Review 7.  Current state and future trends in the diagnosis of babesiosis.

Authors:  R Böse; W K Jorgensen; R J Dalgliesh; K T Friedhoff; A J de Vos
Journal:  Vet Parasitol       Date:  1995-03       Impact factor: 2.738

Review 8.  Equine piroplasmosis an update on diagnosis, treatment and prevention.

Authors:  A Brüning
Journal:  Br Vet J       Date:  1996-03

9.  Monoclonal antibody against Babesia equi: characterization and potential application of antigen for serodiagnosis.

Authors:  A Avarzed; I Igarashi; D T De Waal; S Kawai; Y Oomori; N Inoue; Y Maki; Y Omata; A Saito; H Nagasawa; Y Toyoda; N Suzuki
Journal:  J Clin Microbiol       Date:  1998-07       Impact factor: 5.948

10.  Characterization of pseudorabies virus glycoprotein gII expressed by recombinant baculovirus.

Authors:  X Xuan; T Nakamura; T Ihara; I Sato; K Tuchiya; E Nosetto; A Ishihama; S Ueda
Journal:  Virus Res       Date:  1995-05       Impact factor: 3.303

View more
  19 in total

1.  Improved enzyme-linked immunosorbent assay using C-terminal truncated recombinant antigens of Babesia bovis rhoptry-associated protein-1 for detection of specific antibodies.

Authors:  Suthisak Boonchit; Xuenan Xuan; Naoaki Yokoyama; Will L Goff; Suryakant D Waghela; Gale Wagner; Ikuo Igarashi
Journal:  J Clin Microbiol       Date:  2004-04       Impact factor: 5.948

2.  Detection of antibodies to Babesia equi in horses by a latex agglutination test using recombinant EMA-1.

Authors:  X Xuan; I Igarashi; T Tanaka; S Fukumoto; H Nagasawa; K Fujisaki; T Mikami
Journal:  Clin Diagn Lab Immunol       Date:  2001-05

3.  Conformational dependence and conservation of an immunodominant epitope within the babesia equi erythrocyte-stage surface protein equi merozoite antigen 1.

Authors:  Cristina W Cunha; Lowell S Kappmeyer; Travis C McGuire; Odir A Dellagostin; Donald P Knowles
Journal:  Clin Diagn Lab Immunol       Date:  2002-11

4.  Immunochromatographic test for simultaneous serodiagnosis of Babesia caballi and B. equi infections in horses.

Authors:  Xiaohong Huang; Xuenan Xuan; Rodolfo A Verdida; Shoufa Zhang; Naoaki Yokoyama; Longshan Xu; Ikuo Igarashi
Journal:  Clin Vaccine Immunol       Date:  2006-05

5.  Comparative evaluation of the sensitivity of LAMP, PCR and in vitro culture methods for the diagnosis of equine piroplasmosis.

Authors:  Andy Alhassan; Yadav Govind; Nguyen Thanh Tam; Oriel M M Thekisoe; Naoaki Yokoyama; Noboru Inoue; Ikuo Igarashi
Journal:  Parasitol Res       Date:  2007-01-11       Impact factor: 2.289

6.  High-level expression and purification of a truncated merozoite antigen-2 of Babesia equi in Escherichia coli and its potential for immunodiagnosis.

Authors:  Xiaohong Huang; Xuenan Xuan; Naoaki Yokoyama; Longshan Xu; Hiroshi Suzuki; Chihiro Sugimoto; Hideyuki Nagasawa; Kozo Fujisaki; Ikuo Igarashi
Journal:  J Clin Microbiol       Date:  2003-03       Impact factor: 5.948

7.  Evaluation of Babesia bigemina 200 kDa recombinant antigen in enzyme-linked immunosorbent assay.

Authors:  Khukhuu Altangerel; Andy Alhassan; Hiroshi Iseki; Thillaiampalam Sivakumar; Damdinsuren Boldbaatar; Naoaki Yokoyama; Ikuo Igarashi
Journal:  Parasitol Res       Date:  2009-03-18       Impact factor: 2.289

8.  Identification of a specific antigenic region of the P82 protein of Babesia equi and its potential use in serodiagnosis.

Authors:  Haruyuki Hirata; Xuenan Xuan; Naoaki Yokoyama; Yoshifumi Nishikawa; Kozo Fujisaki; Naoyoshi Suzuki; Ikuo Igarashi
Journal:  J Clin Microbiol       Date:  2003-02       Impact factor: 5.948

9.  A shared antigen among Babesia species: ribosomal phosphoprotein P0 as a universal babesial vaccine candidate.

Authors:  M Alaa Terkawi; Honglin Jia; Aboge Gabriel; Youn-Kyoung Goo; Yoshifumi Nishikawa; Naoaki Yokoyama; Ikuo Igarashi; Kozo Fujisaki; Xuenan Xuan
Journal:  Parasitol Res       Date:  2007-09-06       Impact factor: 2.289

10.  High-level expression of truncated surface antigen P50 of Babesia gibsoni in insect cells by baculovirus and evaluation of its immunogenicity and antigenicity.

Authors:  Shinya Fukumoto; Xuenan Xuan; Kimie Kadota; Ikuo Igarashi; Chihiro Sugimoto; Kozo Fujisaki; Hideyuki Nagasawa; Takeshi Mikami; Hiroshi Suzuki
Journal:  Clin Diagn Lab Immunol       Date:  2003-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.